Deadlines extended for American Cancer Society Chris DiMarco Institutional Research Grant

Through the American Cancer Society Chris DiMarco Institutional Research Grant, UF provides the opportunity for newly independent investigators to receive a one-year award of up to $30,000 for cancer-related research in the areas of basic science, preclinical, epidemiology, clinical, cancer control, psychosocial and behavioral, health service, health policy research, cancer in the poor and underserved, and childhood cancer.


At the time of application, applicants must be:

  1. Independent, self-directed investigators early in their careers, for whom the institution must provide research facilities or space customary for an independent investigator;
  2. Within six cumulative years of their first independent research or faculty appointment (i.e., Assistant Professor and/or Assistant Research Professor Instructor);
  3. United States citizens, noncitizen nationals or permanent residents of the United States. Permanent residents must submit, with the application, notarized evidence indicating they have an Alien Registration Receipt Card or have been approved for the issuance of such card as evidenced by an official passport stamp of the United States Immigration Service and that the form number of the card is I-551.

Applications from underrepresented minorities and women are highly encouraged.

The following are ineligible to apply:

  • Investigators previously funded by this program;
  • Investigators with nationally peer-reviewed funding (including Bankhead Coley or James & Esther King Biomedical Research Award for State of Florida);
  • Investigators with more than 12 years of research experience from their terminal degree;
  • Investigators with overlapping, extramural peer-reviewed support.


Letters of intent are due Feb. 1, 2013.
Full applications are due Feb. 8, 2013.
The anticipated award announcement and start date is March 1, 2013.

Application Instructions

  • Application Instructions & Forms

Contact for Questions

Fay M. Yancey, Division Administrator
UF Division of Hematology & Oncology